JP Morgan Chase’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.4M | Sell |
578,828
-1,702,989
| -75% | -$92.3M | ﹤0.01% | 1703 |
|
|
2025
Q4 | $112M | Sell |
2,281,817
-68,186
| -3% | -$3.18M | 0.01% | 890 |
|
|
2025
Q3 | $101M | Buy |
2,350,003
+110,650
| +5% | +$4.32M | 0.01% | 992 |
|
|
2025
Q2 | $86M | Buy |
2,239,353
+1,839,212
| +460% | +$70.3M | 0.01% | 1004 |
|
|
2025
Q1 | $15.5M | Sell |
400,141
-953,883
| -70% | -$34.9M | ﹤0.01% | 2140 |
|
|
2024
Q4 | $45.8M | Buy |
1,354,024
+983,209
| +265% | +$35.4M | ﹤0.01% | 1383 |
|
|
2024
Q3 | $15.2M | Sell |
370,815
-900,251
| -71% | -$36.8M | ﹤0.01% | 2244 |
|
|
2024
Q2 | $48.9M | Sell |
1,271,066
-470,622
| -27% | -$19.8M | ﹤0.01% | 1256 |
|
|
2024
Q1 | $74.7M | Buy |
1,741,688
+684,309
| +65% | +$28.2M | 0.01% | 1088 |
|
|
2023
Q4 | $39.2M | Buy |
1,057,379
+374,636
| +55% | +$13.4M | ﹤0.01% | 1363 |
|
|
2023
Q3 | $24.7M | Sell |
682,743
-207,825
| -23% | -$7.38M | ﹤0.01% | 1524 |
|
|
2023
Q2 | $31.7M | Buy |
890,568
+569,009
| +177% | +$20.4M | ﹤0.01% | 1367 |
|
|
2023
Q1 | $11.4M | Buy |
321,559
+44,633
| +16% | +$1.56M | ﹤0.01% | 2162 |
|
|
2022
Q4 | $9.73M | Sell |
276,926
-358,245
| -56% | -$11.9M | ﹤0.01% | 2281 |
|
|
2022
Q3 | $18.7M | Buy |
635,171
+195,552
| +44% | +$7.41M | ﹤0.01% | 1626 |
|
|
2022
Q2 | $23.9M | Buy |
439,619
+246,525
| +128% | +$13.6M | ﹤0.01% | 1478 |
|
|
2022
Q1 | $10.5M | Buy |
193,094
+5,935
| +3% | +$322K | ﹤0.01% | 2319 |
|
|
2021
Q4 | $10.3M | Sell |
187,159
-17,025
| -8% | -$886K | ﹤0.01% | 2431 |
|
|
2021
Q3 | $9.75M | Sell |
204,184
-3,078
| -1% | -$155K | ﹤0.01% | 2410 |
|
|
2021
Q2 | $10.3M | Buy |
207,262
+27,737
| +15% | +$1.33M | ﹤0.01% | 2409 |
|
|
2021
Q1 | $8.01M | Buy |
179,525
+23,632
| +15% | +$1.07M | ﹤0.01% | 2564 |
|
|
2020
Q4 | $7.17M | Sell |
155,893
-68,977
| -31% | -$3.17M | ﹤0.01% | 2491 |
|
|
2020
Q3 | $10.5M | Buy |
224,870
+1,532
| +0.7% | +$76.8K | ﹤0.01% | 2000 |
|
|
2020
Q2 | $11.4M | Sell |
223,338
-138,790
| -38% | -$7.12M | ﹤0.01% | 1796 |
|
|
2020
Q1 | $17.2M | Sell |
362,128
-785,969
| -68% | -$41.9M | ﹤0.01% | 1355 |
|
|
2019
Q4 | $67.4M | Sell |
1,148,097
-471,333
| -29% | -$26.2M | 0.01% | 820 |
|
|
2019
Q3 | $86.4M | Buy |
1,619,430
+810,783
| +100% | +$41.7M | 0.02% | 716 |
|
|
2019
Q2 | $40.4M | Buy |
808,647
+264,716
| +49% | +$13.3M | 0.01% | 1087 |
|
|
2019
Q1 | $28.4M | Buy |
543,931
+38,394
| +8% | +$1.92M | 0.01% | 1296 |
|
|
2018
Q4 | $24.1M | Buy |
505,537
+297,472
| +143% | +$14.6M | 0.01% | 1342 |
|
|
2018
Q3 | $10.4M | Sell |
208,065
-15,703
| -7% | -$798K | ﹤0.01% | 2171 |
|
|
2018
Q2 | $11.3M | Buy |
223,768
+106,750
| +91% | +$5.38M | ﹤0.01% | 2044 |
|
|
2018
Q1 | $5.71M | Buy |
117,018
+39,456
| +51% | +$1.84M | ﹤0.01% | 2467 |
|
|
2017
Q4 | $3.44M | Sell |
77,562
-44,882
| -37% | -$2.07M | ﹤0.01% | 2969 |
|
|
2017
Q3 | $6.18M | Sell |
122,444
-50,718
| -29% | -$2.57M | ﹤0.01% | 2390 |
|
|
2017
Q2 | $9.33M | Sell |
173,162
-6,713
| -4% | -$358K | ﹤0.01% | 2021 |
|
|
2017
Q1 | $9.48M | Sell |
179,875
-667,947
| -79% | -$33.9M | ﹤0.01% | 1974 |
|
|
2016
Q4 | $40.8M | Sell |
847,822
-1,734,352
| -67% | -$85.7M | 0.01% | 1009 |
|
|
2016
Q3 | $139M | Sell |
2,582,174
-2,829,079
| -52% | -$155M | 0.04% | 460 |
|
|
2016
Q2 | $293M | Sell |
5,411,253
-2,950,928
| -35% | -$155M | 0.08% | 289 |
|
|
2016
Q1 | $424M | Sell |
8,362,181
-1,652,161
| -16% | -$82.3M | 0.12% | 212 |
|
|
2015
Q4 | $505M | Sell |
10,014,342
-1,133,133
| -10% | -$57.8M | 0.13% | 192 |
|
|
2015
Q3 | $536M | Buy |
11,147,475
+3,757,372
| +51% | +$196M | 0.15% | 169 |
|
|
2015
Q2 | $385M | Buy |
7,390,103
+5,816,017
| +369% | +$327M | 0.1% | 250 |
|
|
2015
Q1 | $90.8M | Sell |
1,574,086
-327,559
| -17% | -$18.8M | 0.02% | 662 |
|
|
2014
Q4 | $102M | Buy |
1,901,645
+384,166
| +25% | +$21.5M | 0.02% | 632 |
|
|
2014
Q3 | $87.2M | Sell |
1,517,479
-25,475
| -2% | -$1.56M | 0.02% | 672 |
|
|
2014
Q2 | $103M | Sell |
1,542,954
-1,578
| -0.1% | -$107K | 0.03% | 565 |
|
|
2014
Q1 | $103M | Buy |
1,544,532
+308,350
| +25% | +$20.8M | 0.03% | 536 |
|
|
2013
Q4 | $82.5M | Buy |
1,236,182
+178,440
| +17% | +$11.6M | 0.02% | 598 |
|
|
2013
Q3 | $66.3M | Sell |
1,057,742
-60,420
| -5% | -$3.89M | 0.02% | 691 |
|
|
2013
Q2 | $69.8M | Buy |
+1,118,162
| New | +$71M | 0.02% | 633 |
|
Other funds holding GSK
JEST
